Dealmaker’s Diary: The 12-Month Money Move That Could Double Your Portfolio

Big money flips stocks yearly now, not every decade. By using the same timeline, we’ve generated 27% returns while others hold deteriorating positions.


Buy This, Not That: Copper Profits From Tariff Tears

With Trump announcing tariffs today, one surprising copper giant offers triple the profit margins and pays you 6.9% to watch the drama unfold.


51% Expect a Market Disaster… So Why Am I Excited?

When retail braces for collapse and big money holds high cash levels, it tends to mark a bottom. We are nowhere near euphoria.


Monday Takeaways: What to Expect With the April 2 Tariff Deadline

Monday Takeaways: What to Expect With the April 2 Tariff Deadline


DOGE Comes for Washington’s Biggest Contractors

Uncle Sam’s diet plan is starving government contractors. Accenture’s shocking 7% stock plunge is just the first casualty of Washington’s new spending diet.


Dealmaker’s Diary: The Rare Disease Fighter Trading at Bargain Prices

This biotech generates positive cash flow while others burn money. At 25x forward earnings, you’re getting tomorrow’s genetic breakthroughs at a discount.


Buy This, Not That: A Tale of Two Balance Sheets

Two tech giants with ugly charts but very different futures…


The Chart Pattern That Scares Billionaires

Markets fell below a critical threshold that legendary trader Paul Tudor Jones warns against. History shows trouble follows when it happens.


Monday Takeaways: Markets at a Crossroads After Finding Support

Markets rally as Trump walks back tariff threats. Shah Gilani explains why crossing 5,700 matters and where hidden risks still lurk.


Market Meltdowns and the Math That Predicts Them

When markets throw tantrums, the VIX reveals their true feelings. Learn to read this drama queen index to time your buys perfectly.


BROUGHT TO YOU BY MANWARD PRESS